For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Axogen Inc (NASDAQ: AXGN) was $29.98 for the day, down -0.10% from the previous closing price of $30.01. In other words, the price has decreased by -$0.10 from its previous closing price. On the day, 0.73 million shares were traded. AXGN stock price reached its highest trading level at $30.28 during the session, while it also had its lowest trading level at $28.88.
Ratios:
Our analysis of AXGN’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 34.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 414.00. For the most recent quarter (mrq), Quick Ratio is recorded 2.64 and its Current Ratio is at 4.09. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.54.
Upgrades & Downgrades
In the most recent recommendation for this company, Mizuho on December 01, 2025, initiated with a Outperform rating and assigned the stock a target price of $40. On March 17, 2025, Lake Street started tracking the stock assigning a Buy rating and target price of $30. On July 01, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $13.Raymond James initiated its Outperform rating on July 01, 2024, with a $13 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 11 ’25 when MARC BEGAN bought 13,222 shares for $30.00 per share.
DALE MICHAEL D sold 61,463 shares of AXGN for $1,918,137 on Dec 09 ’25. The Chief Executive Officer now owns 88,537 shares after completing the transaction at $31.21 per share. On Dec 09 ’25, another insider, TYNDALL JOSEPH A., who serves as the Director of the company, sold 25,108 shares for $30.98 each. As a result, the insider received 777,771 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXGN now has a Market Capitalization of 1382746112 and an Enterprise Value of 1416737280. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.44 while its Price-to-Book (P/B) ratio in mrq is 11.44. Its current Enterprise Value per Revenue stands at 6.598 whereas that against EBITDA is 130.107.
Stock Price History:
The Beta on a monthly basis for AXGN is 1.01, which has changed by 1.1172316 over the last 52 weeks, in comparison to a change of 0.14045572 over the same period for the S&P500. Over the past 52 weeks, AXGN has reached a high of $34.24, while it has fallen to a 52-week low of $9.22. The 50-Day Moving Average of the stock is 31.31%, while the 200-Day Moving Average is calculated to be 80.65%.
Shares Statistics:
AXGN traded an average of 919.45K shares per day over the past three months and 1115240 shares per day over the past ten days. A total of 46.12M shares are outstanding, with a floating share count of 44.96M. Insiders hold about 2.52% of the company’s shares, while institutions hold 89.97% stake in the company. Shares short for AXGN as of 1764288000 were 2849251 with a Short Ratio of 3.10, compared to 1761868800 on 2733034. Therefore, it implies a Short% of Shares Outstanding of 2849251 and a Short% of Float of 6.36.
Earnings Estimates
Axogen Inc (AXGN) is presently subject to a detailed evaluation by 6.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $0.06, with high estimates of $0.1 and low estimates of $0.01.
Analysts are recommending an EPS of between $0.36 and $0.27 for the fiscal current year, implying an average EPS of $0.29. EPS for the following year is $0.49, with 6.0 analysts recommending between $0.63 and $0.43.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 9 analysts. It ranges from a high estimate of $59.8M to a low estimate of $57.5M. As of. The current estimate, Axogen Inc’s year-ago sales were $49.41MFor the next quarter, 9 analysts are estimating revenue of $57.23M. There is a high estimate of $60M for the next quarter, whereas the lowest estimate is $55.6M.
A total of 9 analysts have provided revenue estimates for AXGN’s current fiscal year. The highest revenue estimate was $225.1M, while the lowest revenue estimate was $222.8M, resulting in an average revenue estimate of $223.28M. In the same quarter a year ago, actual revenue was $187.34MBased on 9 analysts’ estimates, the company’s revenue will be $258M in the next fiscal year. The high estimate is $262M and the low estimate is $251M.
